BioClinica creates, fills new leadership position

BioClinica, a producer of products and services used in clinical trials of drugs and medical devices, has hired Andrzej (Andy) Dzik-Jurasz, MD, PhD, as its first senior medical director for medical affairs.

Dzik-Jurasz, an interventional radiologist, has published studies in more than 40 journals, according to a release announcing the appointment. He has also held numerous industry positions, the most recent being executive director of oncology translational imaging with Novartis.

Publicly traded BioClinica is headquartered in Newtown, Pa.
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.